Id |
Subject |
Object |
Predicate |
Lexical cue |
T4 |
0-124 |
Sentence |
denotes |
Hyperactivation of the host immune system during infection by SARS-CoV-2 is the leading cause of death in COVID-19 patients. |
T5 |
125-272 |
Sentence |
denotes |
It is also evident that patients who develop mild/moderate symptoms and successfully recover display functional and well-regulated immune response. |
T6 |
273-475 |
Sentence |
denotes |
Whereas a delayed initial interferon response is associated with severe disease outcome and can be the tipping point towards immunopathological deterioration, often preceding death in COVID-19 patients. |
T7 |
476-565 |
Sentence |
denotes |
Further, adaptive immune response during COVID-19 is heterogeneous and poorly understood. |
T8 |
566-725 |
Sentence |
denotes |
At the same time, some studies suggest activated T and B cell response in severe and critically ill patients and the presence of SARS-CoV2-specific antibodies. |
T9 |
726-904 |
Sentence |
denotes |
Thus, understanding this problem and the underlying molecular pathways implicated in host immune function/dysfunction is imperative to devise effective therapeutic interventions. |
T10 |
905-1057 |
Sentence |
denotes |
In this comprehensive review, we discuss the emerging immunopathological determinants and the mechanism of virus evasion by the host cell immune system. |
T11 |
1058-1316 |
Sentence |
denotes |
Using the knowledge gained from previous respiratory viruses and the emerging clinical and molecular findings on SARS-CoV-2, we have tried to provide a holistic understanding of the host innate and adaptive immune response that may determine disease outcome. |
T12 |
1317-1557 |
Sentence |
denotes |
Considering the critical role of the adaptive immune system during the viral clearance, we have presented the molecular insights of the plausible mechanisms involved in impaired T cell function/dysfunction during various stages of COVID-19. |